Lake Street Advisors Group, LLC Gilead Sciences, Inc. Transaction History
Lake Street Advisors Group, LLC
- $2.05 Billion
- Q2 2024
A detailed history of Lake Street Advisors Group, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Lake Street Advisors Group, LLC holds 17,301 shares of GILD stock, worth $1.47 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
17,301
Previous 18,044
4.12%
Holding current value
$1.47 Million
Previous $1.32 Million
10.14%
% of portfolio
0.06%
Previous 0.06%
Shares
28 transactions
Others Institutions Holding GILD
# of Institutions
1,879Shares Held
1.02BCall Options Held
12MPut Options Held
8.96M-
Black Rock Inc. New York, NY121MShares$10.2 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$9.77 Billion0.15% of portfolio
-
Capital World Investors Los Angeles, CA76.2MShares$6.46 Billion0.88% of portfolio
-
Capital Research Global Investors Los Angeles, CA60.4MShares$5.12 Billion0.94% of portfolio
-
State Street Corp Boston, MA59.3MShares$5.03 Billion0.18% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $106B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...